Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06571344
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-22
Brief Title:
Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to learn about the effects of cholecalciferol administration according to guidelines for the general population on laboratory parameters of Chronic Kidney Disease-Mineral and Bone Disorder in dialysis patients depending of the attained levels of vitamin D 25OHD
The main question it aims to answer is
How does cholecalciferol affect calcium and phosphate metabolism parameters depending on the achieved levels of 25OHD
Participants taking cholecalciferol as part of their regular medical care for CKD-MBD will have the laboratory result parameters observed for up to 4 years
The main question it aims to answer is
How does cholecalciferol affect calcium and phosphate metabolism parameters depending on the achieved levels of 25OHD
Participants taking cholecalciferol as part of their regular medical care for CKD-MBD will have the laboratory result parameters observed for up to 4 years
Detailed Description:
The analysis will involve data obtained from medical records of dialysis patients who receive standard procedures consistent with national and international guidelines for specialized care
Specifically we will analyze the levels of
25OHD
125OH2D
Calcium
Phosphates
PTH
FGF23
GDF15 to assess the efficacy and safety of cholecalciferol in dialysis patients
Specifically we will analyze the levels of
25OHD
125OH2D
Calcium
Phosphates
PTH
FGF23
GDF15 to assess the efficacy and safety of cholecalciferol in dialysis patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None